Skip to main content
OpenTrials
Completed

NCT Number: NCT02292836

Rosacea Prevalence in General Population - Pilot Study

The purpose of this study is to test and refine, a subject questionnaire aimed to be used in a general population rosacea prevalence study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rosacea Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Jerry TAN, Windsor, Ontario, Canada

Loading trial locations.

About this study

The study will test the subject questionnaire aimed to be used in a full general population prevalence study to screen potential subjects with rosacea.

Questionnaire will be self-administrated to Dermatology outpatients.

Testing will be performed at the practice of 2 Dermatologists experts in rosacea who will evaluate subjects' answers and propose fine-tuning of the questionnaire content, if needed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Male or Female aged between 18 (or locally accepted majority) and 65 years old both included.
  • Subject visiting one of the study dermatology practices for daily care/routine dermatology consultation.
  • Subject have to read and sign the approved Informed Consent form prior to any participation in the study,
  • Subject willing and capable of cooperating to the extend and degree required by the protocol

Treatment and study plan

Questionnaire testing

Other

Questionnaire testing on rosacea and non-rosacea dermatology outpatients

Primary outcomes

  1. sensitivity and specificity of questions

    Time frame: Day 1

    sensitivity and specificity of each questionnaire key items by comparing subject answers and investigator assessments, as follows: Sensitivity= True Positive/(True Positive+False Negative)

    Specificity= True Negative/ (False Positive+True Negative)

Sponsors and collaborators

Lead sponsor

Galderma R&D

Industry

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Nov 17, 2014
Registry last updated
Nov 17, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.